{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:00:42Z","timestamp":1762099242286,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["heartrhythmopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm O2"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.hroo.2024.02.002","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T12:58:56Z","timestamp":1708001936000},"page":"201-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Outcomes and care quality metrics for people living with rheumatic heart disease and atrial fibrillation in Uganda"],"prefix":"10.1016","volume":"5","author":[{"given":"Chinonso C.","family":"Opara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy H.","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joselyn","family":"Rwebembera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmy","family":"Okello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew Y.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris T.","family":"Longenecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hroo.2024.02.002_bib1","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJMoa1603693","article-title":"Global, regional, and national burden of rheumatic heart disease, 1990-2015","volume":"377","author":"Watkins","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2024.02.002_bib2","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2024.02.002_bib3","first-page":"222","article-title":"Current perspectives: rheumatic atrial fibrillation","volume":"2","author":"Shankar","year":"2010","journal-title":"J Atr Fibrillation"},{"key":"10.1016\/j.hroo.2024.02.002_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.5334\/gh.807","article-title":"Meta-analysis of the incidence, prevalence, and correlates of atrial fibrillation in rheumatic heart disease","volume":"15","author":"Noubiap","year":"2020","journal-title":"Glob Heart"},{"key":"10.1016\/j.hroo.2024.02.002_bib5","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.hroo.2024.02.002_bib6","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.STR.32.2.392","article-title":"Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe","volume":"32","author":"Lamassa","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.hroo.2024.02.002_bib7","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/europace\/euq006","article-title":"Atrial fibrillation in Africa: clinical characteristics, prognosis, and adherence to guidelines in Cameroon","volume":"12","author":"Ntep-Gweth","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2024.02.002_bib8","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2024.02.002_bib9","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2024.02.002_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2024.02.002_bib11","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/europace\/eux240","volume":"19","author":"Lip","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2024.02.002_bib12","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1056\/NEJMoa2209051","article-title":"Rivaroxaban in rheumatic heart disease\u2013associated atrial fibrillation","volume":"387","author":"Connolly","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2024.02.002_bib13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ihj.2020.07.004","article-title":"A pilot study on the acute conversion and maintenance of sinus rhythm in rheumatic atrial fibrillation using oral flecainide","volume":"72","author":"Ghosh","year":"2020","journal-title":"Indian Heart J"},{"key":"10.1016\/j.hroo.2024.02.002_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/europace\/eun302","article-title":"Acute beta-adrenoceptor blockade improves efficacy of ibutilide in conversion of atrial fibrillation with a rapid ventricular rate","volume":"11","author":"Fragakis","year":"2009","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2024.02.002_bib15","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/hrt.2005.080325","article-title":"Comparison of rate control and rhythm control in patients with atrial fibrillation after percutaneous mitral balloon valvotomy: a randomised controlled study","volume":"92","author":"Hu","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.hroo.2024.02.002_bib16","first-page":"110","article-title":"Control of rate versus rhythm in rheumatic atrial fibrillation: a randomized study","volume":"56","author":"Vora","year":"2004","journal-title":"Indian Heart J"},{"key":"10.1016\/j.hroo.2024.02.002_bib17","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1159\/000516590","article-title":"Safety and efficacy of ibutilide for acute pharmacological cardioversion of rheumatic atrial fibrillation","volume":"146","author":"Shenthar","year":"2021","journal-title":"Cardiology"},{"key":"10.1016\/j.hroo.2024.02.002_bib18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0167-5273(89)90223-4","article-title":"Digoxin or verapamil or metoprolol for heart rate control in patients with mitral stenosis \u2014 a randomised cross-over study","volume":"25","author":"Ahuja","year":"1989","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hroo.2024.02.002_bib19","first-page":"159","article-title":"Relationship between control of ventricular rate in atrial fibrillation and systemic coagulation activation in patients with mitral stenosis","volume":"13","author":"Atak","year":"2004","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.hroo.2024.02.002_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.117.004037","article-title":"Rheumatic heart disease treatment cascade in Uganda","volume":"10","author":"Longenecker","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.hroo.2024.02.002_bib21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.gheart.2018.02.002","article-title":"A human-centered approach to CV care: infrastructure development in Uganda","volume":"13","author":"Longenecker","year":"2018","journal-title":"Glob Heart"},{"key":"10.1016\/j.hroo.2024.02.002_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015562","article-title":"Outcomes and care quality metrics for women of reproductive age living with rheumatic heart disease in Uganda","volume":"9","author":"Chang","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hroo.2024.02.002_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.008445","article-title":"Mortality along the rheumatic heart disease cascade of care in Uganda","volume":"15","author":"Chang","year":"2022","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.hroo.2024.02.002_bib24","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1093\/cid\/ciab681","article-title":"Clinical outcomes, echocardiographic findings, and care quality metrics for people living with human immunodeficiency virus (HIV) and rheumatic heart disease in Uganda","volume":"74","author":"Chang","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.hroo.2024.02.002_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/heartasia-2017-010981","article-title":"Impact of regionalisation of a national rheumatic heart disease registry: the Ugandan experience","volume":"10","author":"Okello","year":"2018","journal-title":"Heart Asia"},{"key":"10.1016\/j.hroo.2024.02.002_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2008.11.029","article-title":"Echocardiographic assessment of valve stenosis: EAE\/ASE recommendations for clinical practice","volume":"22","author":"Baumgartner","year":"2009","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.hroo.2024.02.002_bib27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.thromres.2005.08.007","article-title":"Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis","volume":"118","author":"Lip","year":"2006","journal-title":"Thromb Res"},{"key":"10.1016\/j.hroo.2024.02.002_bib28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijcard.2020.09.020","article-title":"Economic consequences of rheumatic heart disease: a scoping review","volume":"323","author":"Opara","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hroo.2024.02.002_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.636280","article-title":"Household economic consequences of rheumatic heart disease in Uganda","volume":"8","author":"Opara","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.hroo.2024.02.002_bib30","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCULATIONAHA.116.024769","article-title":"Clinical outcomes in 3343 children and adults with rheumatic heart disease from 14 low-and middle-income countries: two-year follow-up of the Global Rheumatic Heart Disease Registry (the REMEDY study)","volume":"134","author":"Z\u00fchlke","year":"2016","journal-title":"Circulation"}],"container-title":["Heart Rhythm O2"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266650182400028X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266650182400028X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T08:03:54Z","timestamp":1713513834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266650182400028X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S266650182400028X"],"URL":"https:\/\/doi.org\/10.1016\/j.hroo.2024.02.002","relation":{},"ISSN":["2666-5018"],"issn-type":[{"type":"print","value":"2666-5018"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes and care quality metrics for people living with rheumatic heart disease and atrial fibrillation in Uganda","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm O2","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hroo.2024.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Heart Rhythm Society. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}